The US life sciences job market is showing signs of recovery, with a notable 2.1% growth in biotech employment anticipated for 2026, following a period of decline. This rebound is fueled by a 33% increase in venture capital funding during the first half of the year, suggesting a promising outlook for hiring in the sector.
Despite the overall positive trend, the recovery is unevenly distributed across the country. While cities like Chicago, New York's suburbs, and Philadelphia are experiencing job growth, traditional biotech strongholds such as Boston and San Francisco have seen job losses. Ian Anderson from CBRE attributes this shift to the diverse economic foundations of the emerging markets, which are less reliant on heavy R&D compared to their coastal counterparts.
Interestingly, even with rising employment and funding, lab vacancies remain at record highs. This is primarily due to companies downsizing from the excess space they acquired during the 2021 boom, rather than a shift towards more efficient lab usage driven by AI technologies. Anderson notes that while AI's impact on lab space is currently negligible, changes in educational trends suggest a shift towards skills aligned with future technological advancements.
Overall, the landscape of life sciences employment is evolving, with implications for both the workforce and the real estate market. As companies navigate the transition from excess space to a more balanced approach, the focus will likely remain on adapting to the changing dynamics of talent and technology in the sector.